J9301 HCPCS code: Injection, obinutuzumab, 10 mg
J9301 is the HCPCS Level II code for injection, obinutuzumab, 10 mg. In 2024 Medicare paid an average of $56.03 per service for J9301 across 1,040,186 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 100 per day on outpatient hospital claims. Medicare volume rose 6% from 2022 to 2024 (977,630 to 1,040,186 services). In 2024, about 2,026 clinicians billed Medicare for J9301 for 2,056 beneficiaries; Florida, Texas, California accounted for 32% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2015-01-01 |
| Last action effective | 2015-01-01 |
Who bills J9301 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,026 |
| Medicare beneficiaries | 2,056 |
| States with claims | 38 |
| Share of services in top 3 states (Florida, Texas, California) | 32% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9301, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 977,630 | 1,965 | $63.87 | $51.00 |
| 2023 | 1,031,384 | 2,016 | $66.80 | $53.22 |
| 2024 | 1,040,186 | 2,056 | $70.34 | $56.03 |
States with the most J9301 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 116,536 | $56.42 |
| Texas | 102,520 | $55.72 |
| California | 102,200 | $56.31 |
| Arizona | 65,620 | $56.49 |
| Illinois | 56,720 | $55.94 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 100 | Prescribing Information |
What changed for J9301
- 2015-01-01: J9301 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9301?
J9301 is the HCPCS Level II code for injection, obinutuzumab, 10 mg. Short descriptor: "Obinutuzumab inj".
How much does Medicare pay for J9301?
In 2024, the average Medicare payment was $56.03 per service (average allowed $70.34).
Does Medicare cover J9301?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9301 can be billed per day?
100 on outpatient hospital claims; 100 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
- J9312 — Injection, rituximab, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9301
- Watch J9301 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9301
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.